Effects of opioids and sedatives on survival in an Australian inpatient palliative care population

被引:59
作者
Good, PD
Ravenscroft, PJ
Cavenagh, J
机构
[1] Newcastle Mater Misericordiae Hosp, Div Palliat Care, Waratah, Australia
[2] Univ Newcastle, Fac Hlth, Callaghan, NSW, Australia
关键词
palliative care; survival analysis; narcotics; therapeutic use; hypnotics and sedatives; double effect;
D O I
10.1111/j.1445-5994.2005.00888.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims: To assess whether opioid and sedative medication use affects survival (from hospice admission to death) of patients in an Australian inpatient palliative care unit. Background: Retrospective audit. Newcastle Mercy Hospice - a tertiary referral palliative care unit. All patients who died in the hospice between 1 February and 31 December 2000. Methods: Length of survival from hospice admission to death, and the median and mean doses of opioids and sedatives used in the last 24 h of life. Comparison of these with published studies outside of Australia. Results: In this study, the use of opioids, benzodiazepines and haloperidol did not have an association with shortened survival and the only statistical significant finding was an increased survival in patients who were on 300 mg/day or more of oral morphine equivalent (OME). The proportion of patients requiring greater than or equal to 300 mg OME/day (at 28%) was higher than published studies, but the mean dose of 371 mg OME/day was within the range of other studies. The proportion of patients receiving sedatives (94%) was higher than other studies, but the median dose of parenteral midazolam equivalent of 12.5 mg per 24 h was lower than other studies from outside Australia. Conclusions: There was no association between the doses of opioids and sedatives on the last day of life and survival (from hospice admission to death) in this population of palliative care patients.
引用
收藏
页码:512 / 517
页数:6
相关论文
共 35 条
[21]  
Morita T, 1998, Am J Hosp Palliat Care, V15, P217, DOI 10.1177/104990919801500407
[22]   Morphine drips, terminal sedation, and slow euthanasia: Definitions and facts, not anecdotes [J].
Mount, B .
JOURNAL OF PALLIATIVE CARE, 1996, 12 (04) :31-37
[23]   Sedation in palliative care – a critical analysis of 7 years experience [J].
H Christof Muller-Busch ;
Inge Andres ;
Thomas Jehser .
BMC Palliative Care, 2 (1)
[24]   THE AMBIGUITY OF CLINICAL INTENTIONS [J].
QUILL, TE .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 329 (14) :1039-1040
[25]   Anxiety disorders in cancer patients: Their nature, associations, and relation to quality of life [J].
Stark, D ;
Kiely, M ;
Smith, A ;
Velikova, G ;
House, A ;
Selby, P .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (14) :3137-3148
[26]   ACUTE CONFUSIONAL STATES IN PATIENTS WITH ADVANCED CANCER [J].
STIEFEL, F ;
FAINSINGER, R ;
BRUERA, E .
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 1992, 7 (02) :94-98
[27]   A comparison of the use of sedatives in a hospital support team and in a hospice [J].
Stone, P ;
Phillips, C ;
Spruyt, O ;
Waight, C .
PALLIATIVE MEDICINE, 1997, 11 (02) :140-144
[28]   The use of opioids and sedatives at the end of life [J].
Sykes, N ;
Thorns, A .
LANCET ONCOLOGY, 2003, 4 (05) :312-318
[29]   Sedative use in the last week of life and the implications for end-of-life decision making [J].
Sykes, N ;
Thorns, A .
ARCHIVES OF INTERNAL MEDICINE, 2003, 163 (03) :341-344
[30]   Opioid use in last week of life an implications for end-of-life decision-making [J].
Thorns, A ;
Sykes, N .
LANCET, 2000, 356 (9227) :398-399